| Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury F Hellal, A Hurtado, J Ruschel, KC Flynn, CJ Laskowski, M Umlauf, ... Science 331 (6019), 928-931, 2011 | 631 | 2011 |
| Systemic administration of epothilone B promotes axon regeneration after spinal cord injury J Ruschel, F Hellal, KC Flynn, S Dupraz, DA Elliott, A Tedeschi, M Bates, ... Science 348 (6232), 347-352, 2015 | 438 | 2015 |
| Electrical activity suppresses axon growth through Cav1. 2 channels in adult primary sensory neurons J Enes, N Langwieser, J Ruschel, MM Carballosa-Gonzalez, A Klug, ... Current Biology 20 (13), 1154-1164, 2010 | 107 | 2010 |
| Rhythmicity in mice selected for extremes in stress reactivity: behavioural, endocrine and sleep changes resembling endophenotypes of major depression C Touma, T Fenzl, J Ruschel, R Palme, F Holsboer, M Kimura, R Landgraf PLoS One 4 (1), e4325, 2009 | 90 | 2009 |
| Systemic administration of epothilone D improves functional recovery of walking after rat spinal cord contusion injury J Ruschel, F Bradke Experimental neurology 306, 243-249, 2018 | 63 | 2018 |
| Systemic epothilone D improves hindlimb function after spinal cord contusion injury in rats B Sandner, R Puttagunta, M Motsch, F Bradke, J Ruschel, A Blesch, ... Experimental Neurology 306, 250-259, 2018 | 60 | 2018 |
| Sleep disturbances in highly stress reactive mice: modeling endophenotypes of major depression T Fenzl, C Touma, CPN Romanowski, J Ruschel, F Holsboer, R Landgraf, ... BMC neuroscience 12, 1-12, 2011 | 59 | 2011 |
| A brain-targeted orally available ROCK2 inhibitor benefits mild and aggressive cavernous angioma disease L McKerracher, R Shenkar, M Abbinanti, Y Cao, A Peiper, JK Liao, ... Translational stroke research 11, 365-376, 2020 | 27 | 2020 |
| Rho kinase inhibitor BA-1049 (R) and active metabolites thereof KM Rosen, MD Abbinanti, J Ruschel, L McKerracher, LB Moritz US Patent 10,106,525, 2018 | 12 | 2018 |
| Rho kinase inhibitor BA-1049 (R) and active metabolites thereof KM Rosen, MD Abbinanti, J Ruschel, L McKerracher, LB Moritz US Patent 10,526,313, 2020 | 3 | 2020 |
| Rho kinase inhibitor BA-1049 (R) and active metabolites thereof KM Rosen, MD Abbinanti, J Ruschel, L McKerracher, LB Moritz US Patent 11,198,680, 2021 | 2 | 2021 |
| Kinase inhibitors for treatment of disease J Ruschel, MD Abbinanti, KM Rosen, L McKerracher US Patent 10,537,567, 2020 | 2 | 2020 |
| Rho kinase inhibitor ba-1049 (r) and active metabolites thereof KM Rosen, MD ABBINANTI, J RUSCHEL, L Mckerracher, LB MORTIZ | 1 | 2018 |
| Rho kinase inhibitor BA-1049 (R) and active metabolites thereof KM Rosen, MD Abbinanti, J Ruschel, L McKerracher, LB Moritz US Patent 11,814,361, 2023 | | 2023 |
| Self-delivering RNAi compounds as therapeutic agents in the central nervous system to enhance axonal regeneration after injury SA Woller, J Ruschel, B Morquette, J Cardia, D Yan, K Holton, ... Iscience 25 (6), 2022 | | 2022 |
| TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS J Ruschel, L McKerracher, E Niederst, KM Rosen US Patent App. 17/380,756, 2022 | | 2022 |
| Treatment of CNS injury with RNAi therapeutics J Ruschel, L McKerracher, E Niederst, KM Rosen US Patent 11,098,308, 2021 | | 2021 |
| RHO KINASE BA-1049 (R) INHIBITOR AND ITS ACTIVE METABOLITES KM Rosen, MD ABBINANTI, J RUSCHEL, L Mckerracher, LB MORITZ | | 2020 |
| SELF-DELIVERING RNA TO EVALUATE PTEN AS A THERAPEUTIC TARGET TO PROMOTE AXON REGENERATION L McKerracher, T Shmushkovich, M Abbinanti, L Guo, J Ruschel, F Yang, ... JOURNAL OF NEUROTRAUMA 33 (13), A130-A130, 2016 | | 2016 |
| Sleep/wake behavior in the stress reactivity mouse model-a new animal model to investigate sleep impairments in major depression T Fenzl, J Ruschel, C Touma, CP Romanowski, R Landgraf, M Kimura Journal of Sleep Research 17 (Suppl. 1), 261-261, 2008 | | 2008 |
